Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Keratosis, Actinic × Niacin × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Depression 3 Anxiety Disorders 3 Skin Neoplasms 2 Neoplasms 2 Polycystic Ovary Syndrome 1 Keratosis, Actinic 1 Hand-Foot Skin Reaction (HFSR) 1 Glioblastoma 1

Interventions

3-ingenyl angelate 37 Aminolevulinic Acid 29 Imiquimod 24 Fluorouracil 22 Photochemotherapy 21 Gels 12 Cryotherapy 12 Diclofenac 11 methyl 5-aminolevulinate 10 tirbanibulin 6 calcipotriene 5 Solutions 5 Petrolatum 5 Ointments 5 LEO 43204 5 Radiotherapy 4 Prilocaine 4 Lidocaine 4 BF-200 ALA 4 Therapeutics 3 Niacinamide 3 Cryosurgery 3 1-phenyl-3,3-dimethyltriazene 3 SR-T100 2 Phototherapy 2 Imipramine 2 Deoxyribonuclease (Pyrimidine Dimer) 2 Celecoxib 2 tazarotene 1 potassium dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04843553 2021-04-22

NICE

Rhode Island Hospital

Phase EARLY_PHASE1 Completed

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡